<page_title> 17β-Dihydroequilin </page_title> <section_title> Pharmacodynamics </section_title> <table> <cell> 17β-Dihydroequilin <col_header> Compound </col_header> </cell> <cell> 113 <col_header> RBA for ERα (%) </col_header> </cell> <cell> 108 <col_header> RBA for ERβ (%) </col_header> </cell> </table>
In terms of relative binding affinity for the ERs, 17β-dihydroequilin has 113% and 108% of ERα and ERβ.